165
Participants
Start Date
September 14, 2017
Primary Completion Date
February 15, 2019
Study Completion Date
May 15, 2019
GSK3772847
GSK3772847 10 mg/kg will be administered as IV infusion once every 4 weeks to randomized subjects.
Placebo
Placebo sterile normal saline will be administered as IV infusion once every 4 weeks to randomized subjects.
Fluticasone propionate/salmeterol
FP/Sal 500/50 mcg will be administered via inhalation route twice daily to all subjects.
Fluticasone propionate
FP 500, 250, 100 or 50 mcg will be administered via inhalation route twice daily to all subjects.
GSK Investigational Site, Melbourne
GSK Investigational Site, Parkville
GSK Investigational Site, Clayton
GSK Investigational Site, Woodville South
GSK Investigational Site, México DF
GSK Investigational Site, Rochester
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Baltimore
GSK Investigational Site, Williamsburg
GSK Investigational Site, Mooresville
GSK Investigational Site, Charlotte
GSK Investigational Site, Adairsville
GSK Investigational Site, Winter Park
GSK Investigational Site, Hialeah
GSK Investigational Site, Coral Gables
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Birmingham
GSK Investigational Site, Scottsboro
GSK Investigational Site, Toledo
GSK Investigational Site, Guadalajara
GSK Investigational Site, Cincinnati
GSK Investigational Site, Madison
GSK Investigational Site, Cuernavaca
GSK Investigational Site, St Louis
GSK Investigational Site, Monterrey
GSK Investigational Site, Tulsa
GSK Investigational Site, Boerne
GSK Investigational Site, Villahermosa
GSK Investigational Site, Los Angeles
GSK Investigational Site, Long Beach
GSK Investigational Site, Newport Beach
GSK Investigational Site, Bakersfield
GSK Investigational Site, Mérida
GSK Investigational Site, Medford
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Ulyanovsk
GSK Investigational Site, Samara
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Tomsk
GSK Investigational Site, Kemerovo
GSK Investigational Site, New Haven
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Sherwood Park
GSK Investigational Site, Vancouver
GSK Investigational Site, Vancouver
GSK Investigational Site, Hamilton
GSK Investigational Site, Ottawa
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Québec
GSK Investigational Site, Mexico City
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY